MODERNA Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations.
Together with Pfizer Inc's vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available by the year's end.
Next year, the U.S. government could have access to more than 1 billion doses just from the two vaccine makers, more than needed for the country's 330 million residents.
The vaccines, both built using new technology known as messenger RNA or mRNA, represent powerful new tools to fight a pandemic that has infected 54 million people worldwide and killed 1.3 million. The news also comes at time when COVID-19 cases are soaring, hitting new records in the United States and pushing some European countries back into lockdowns.
"We are going to have a vaccine that can stop COVID-19," Moderna President Stephen Hoge said in a telephone interview.
Moderna's interim analysis was based on 95 infections among trial participants who received either a placebo or the vaccine. Of those, only five infections occurred in those who received the vaccine, which is administered in two shots 28 days apart.
A key advantage of Moderna's vaccine is that it does not need ultra-cold storage like Pfizer's, making it easier to distribute. Moderna expects it to be stable at standard refrigerator temperatures of 2 to 8 degrees Celsius (36 to 48°F) for 30 days and it can be stored for up to 6 months at -20 degrees Celsius.
Pfizer’s vaccine must be shipped and stored at minus 70 degrees Celsius, the sort of temperature typical of an Antarctic winter. At standard refrigerator temperatures, it can be stored for up to five days.
The data from Moderna's 30,000 participant-strong trial also showed the vaccine prevented cases of severe COVID-19, a question that still remains with the Pfizer vaccine. Of the 95 cases in Moderna's trial, 11 were severe and all 11 occurred among volunteers who got the placebo.
Moderna, part of the U.S. government's Operation Warp Speed program, expects to produce around 20 million doses of the vaccine for the United States this year, millions of which the company has already made, and is ready to ship if it receives FDA authorization.
"Assuming we get an emergency use authorization, we'll be ready to ship through Warp Speed almost in hours," Hoge said. "So it could start being distributed instantly."
DATA DETAILS
The 95 cases of COVID-19 included several key groups who are at increased risk for severe disease, including 15 cases in adults aged 65 and older and 20 in participants from racially diverse groups.
Most side effects were mild to moderate. A significant proportion of volunteers, however, experienced more severe aches and pains after taking the second dose, including about 10% who had fatigue severe enough to interfere with daily activities while another 9% had severe body aches. Most of these complaints were generally short-lived, the company said.
Moderna's data provide further validation of the promising but previously unproven mRNA platform, which turns the human body into a vaccine factory by coaxing cells to make certain virus proteins that the immune system sees as a threat and mounts a response against.
Moderna expects to have enough safety data required for U.S. authorization in the next week or so and the company expects to file for emergency use authorization in the coming weeks.
The United States has the world's highest known number of COVID-19 cases and deaths with more than 11 million infections and nearly 250,000 deaths.
The Trump Administration has primarily relied on development of vaccines and treatments as its response to the pandemic. Moderna has received nearly $1 billion in research and development funding from the U.S. government and has a $1.5 billion deal for 100 million doses. The U.S. government also has an option for another 400 million doses.
The company hopes to have between 500 million and 1 billion doses in 2021, split between its U.S. and international manufacturing sites and dependent in part on demand.
The U.S. government has said COVID-19 vaccines will be provided free to Americans, whether they have health insurance, are uninsured or are covered by government health programs such as Medicare.
Moderna also said it will use its data to seek authorization in Europe and other regions.
Other countries such as China and Russia have already begun vaccinations. Russia licensed its “Sputnik-V” COVID-19 vaccine for domestic use in August before it released data from large-scale trials. It said on Nov. 11 that its vaccine was 92% effective based on 20 infections in its large trial.
Reuters
Mon Nov 16 2020
![Moderna says its vaccine is 94.5% effective in preventing COVID-19 Moderna says its vaccine is 94.5% effective in preventing COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2020-11/61605528925_vaccine.jpg)
Vials with a sticker reading "COVID-19/Coronavirus vaccine/Injection only" and a syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. - REUTERS
Putin anggap rundingan dengan Ukraine tidak berguna
Presiden Rusia Vladimir Putin menyifatkan, tindakan Ukraine yang menyerang orang awam memperlihatkan keengganan Kyiv menyelesaikan konflik peperangan dua negara dengan cara perdamaian.
Fadillah tiba di Peru, hadiri mesyuarat menteri-menteri tenaga APEC 2024
Timbalan Perdana Menteri, Datuk Seri Fadillah Yusof tiba Lima, Peru bagi menghadiri Mesyuarat Menteri-Menteri Tenaga (EMM) di bawah Kerjasama Ekonomi Asia Pasifik (APEC) yang berlangsung selama dua hari.
BNM denda Maybank RM4.32 juta, CIMB RM760,000 berikutan gangguan perkhidmatan berpanjangan
Bank Negara Malaysia mengenakan Penalti Monetari Pentadbiran (AMP) sebanyak RM4.32 juta ke atas Malayan Banking Bhd dan Maybank Islamic Bhd serta RM760,000 ke atas CIMB Bank Bhd dan CIMB Islamic Bank Bhd susulan gangguan beberapa perkhidmatan perbankan yang berpanjangan.
![Pertubuhan kebajikan New Zealand mohon maaf edar gula-gula bercampur dadah Methamphetamine Pertubuhan kebajikan New Zealand mohon maaf edar gula-gula bercampur dadah Methamphetamine](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/41723674988_pineapplesweetsme.jpg)
Pertubuhan kebajikan New Zealand mohon maaf edar gula-gula bercampur dadah Methamphetamine
Auckland City Mission secara tidak sengaja telah mengagihkan gula-gula bercampur Methamphetamine yang boleh membawa maut melalui pek makanan.
Pesakit buah pinggang di Gaza hadapi kekurangan mesin dialisis
Pesakit buah pinggang di Gaza menghadapi kekurangan peralatan dialisis dan bekalan perubatan yang teruk di Khan Younis.
Kekejaman zionis: Hamas hilang kepercayaan A.S jadi pengantara gencatan senjata
Hamas hilang kepercayaan terhadap keupayaan Amerika Syarikat untuk menjadi pengantara gencatan senjata di Gaza.
Kekejaman zionis: Hamas tidak ambil bahagian rundingan gencatan senjata baharu
Hamas tidak akan mengambil bahagian dalam pusingan baharu rundingan gencatan senjata Gaza yang dijadualkan di Qatar, pada Khamis.
Malaysia kecam pencerobohan Israel ke atas Masjid Al-Aqsa
Wisma Putra dalam satu kenyataan pada Rabu berkata perbuatan keji ini yang dilakukan di bawah perlindungan pasukan keselamatan Israel, merupakan pencerobohan serius terhadap satu daripada tapak paling suci Islam.
![WHO isytihar mpox sebagai kecemasan kesihatan awam global WHO isytihar mpox sebagai kecemasan kesihatan awam global](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/41723675747_Mpoxvirus.jpg)
WHO isytihar mpox sebagai kecemasan kesihatan awam global
Ini merupakan pengisytiharan kali kedua dalam tempoh dua tahun berikutan wabak yang bermula di Congo sudah merebak ke negara jiran.
![Turkiye akan terus tingkatkan tekanan ke atas Israel - Presiden Erdogan Turkiye akan terus tingkatkan tekanan ke atas Israel - Presiden Erdogan](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2024-08/81723674774_TayyipEMahmoudAbbas.jpg)
Turkiye akan terus tingkatkan tekanan ke atas Israel - Presiden Erdogan
Erdogan maklumkan kepada Presiden Mahmoud Abbas, Turkiye akan terus sokong perjuangan Palestin.
![Belgium akan musnahkan hampir 6 juta vaksin COVID-19 yang luput Belgium akan musnahkan hampir 6 juta vaksin COVID-19 yang luput](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-06/81655771240_VialswithPfizerBi.jpg)
Belgium akan musnahkan hampir 6 juta vaksin COVID-19 yang luput
Belgium tidak boleh menggunakan lagi lebihan vaksin asli dan 2.6 juta dos Moderna dan 3.3 juta dos Pfizer akan dimusnahkan secepat mungkin.
![Vaksin COVID-19: AS setuju cadangan dos penggalak kepada 12 tahun ke atas Vaksin COVID-19: AS setuju cadangan dos penggalak kepada 12 tahun ke atas](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-01/41643157209_COVIDvaccine.jpg)
Vaksin COVID-19: AS setuju cadangan dos penggalak kepada 12 tahun ke atas
CDC dijangka menerima pakai cadangan itu, sebagai langkah sebelum suntikan boleh dimulakan.
![Moderna saman Pfizer, BioNTech kerana tiru paten Moderna saman Pfizer, BioNTech kerana tiru paten](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-06/81655771240_VialswithPfizerBi.jpg)
Moderna saman Pfizer, BioNTech kerana tiru paten
Moderna mendakwa, kedua-dua syarikat itu meniru teknologi yang dihasilkannya sejak sekian lama sebelum pandemik bermula.
![Britain negara pertama lulus vaksin sasar dua varian COVID-19 Britain negara pertama lulus vaksin sasar dua varian COVID-19](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-08/81630090384_moderna.jpg)
Britain negara pertama lulus vaksin sasar dua varian COVID-19
Agensi Kawal Selia Kesihatan dan Perubatan UK memaklumkan ia memberi lampu hijau untuk vaksin berkenaan yang akan digunakan sebagai dos penggalak dewasa.
![COVID-19: Vaksin Pfizer, Moderna lulus untuk kanak-kanak 6 bulan ke 5 tahun COVID-19: Vaksin Pfizer, Moderna lulus untuk kanak-kanak 6 bulan ke 5 tahun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-02/71644316981_PICKids.jpg)
COVID-19: Vaksin Pfizer, Moderna lulus untuk kanak-kanak 6 bulan ke 5 tahun
Dengan kelulusan ini, sekitar 18 juta kanak-kanak dalam kumpulan umur berkenaan layak untuk menerima vaksin.
![Berita antarabangsa pilihan sepanjang hari ini Berita antarabangsa pilihan sepanjang hari ini](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-03/61648036783_TBBERITAx.jpg)
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang Jumaat, 29 April 2022.
![Moderna minta FDA luluskan vaksin COVID-19 untuk kanak-kanak bawah 6 tahun Moderna minta FDA luluskan vaksin COVID-19 untuk kanak-kanak bawah 6 tahun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-05/81620252572_TBmodernavaccine.jpg)
Moderna minta FDA luluskan vaksin COVID-19 untuk kanak-kanak bawah 6 tahun
Vaksin dua dos itu dilaporkan 51 peratus berkesan terhadap jangkitan varian Omicron pada bayi berumur enam bulan hingga dua tahun.
![COVID-19: Britain lulus vaksin Moderna untuk kanak-kanak 6-11 tahun COVID-19: Britain lulus vaksin Moderna untuk kanak-kanak 6-11 tahun](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2022-02/51644985374_vaccine.jpg)
COVID-19: Britain lulus vaksin Moderna untuk kanak-kanak 6-11 tahun
Kelulusan diberikan selepas vaksin dikenali sebagai Spikevax itu memenuhi piawaian keselamatan, kualiti dan keberkesanan yang diperlukan.
![COVID-19: Moderna dakwa vaksin keluarannya berkesan terhadap bayi, kanak-kanak COVID-19: Moderna dakwa vaksin keluarannya berkesan terhadap bayi, kanak-kanak](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-08/51628157125_moderna.jpg)
COVID-19: Moderna dakwa vaksin keluarannya berkesan terhadap bayi, kanak-kanak
Sekiranya pengawal selia Amerika Syarikat bersetuju, ia memberi peluang kepada pemberian vaksin kepada kanak-kanak menjelang musim panas.
![Moderna rancang tubuh anak syarikat baharu di Malaysia Moderna rancang tubuh anak syarikat baharu di Malaysia](https://resizer-awani.eco.astro.com.my/tr:w-177,h-100,q-100,f-auto/https://img.astroawani.com/2021-05/81620252572_TBmodernavaccine.jpg)
Moderna rancang tubuh anak syarikat baharu di Malaysia
Syarikat bioteknologi yang merintis terapeutik dan vaksin messenger RNA (mRNA), Moderna, Inc. hari ini mengumumkan rancangan untuk menubuhkan anak syarikat baharu di Malaysia, disertai tiga anak syari